Literature DB >> 28456860

Downbeat nystagmus as an initial clinical sign in spinocerebellar ataxia type 6.

Tatsuya Ueno1, Hisanori Nishizawa2, Chieko Suzuki3, Jin-Ichi Nunomura3, Masahiko Tomiyama3.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28456860     DOI： 10.1007/s10072-017-2973-y

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  Positional vertigo and macroscopic downbeat positioning nystagmus in spinocerebellar ataxia type 6 (SCA6).

Authors:  Ichiro Yabe; Hidenao Sasaki; Norihito Takeichi; Asako Takei; Takeshi Hamada; Kikuro Fukushima; Kunio Tashiro
Journal:  J Neurol       Date:  2003-04       Impact factor: 4.849

2.  Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset.

Authors:  C M Gomez; R M Thompson; J T Gammack; S L Perlman; W B Dobyns; C L Truwit; D S Zee; H B Clark; J H Anderson
Journal:  Ann Neurol       Date:  1997-12       Impact factor: 10.422

Review 3.  Sporadic ataxia with adult onset: classification and diagnostic criteria.

Authors:  Thomas Klockgether
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

Review 4.  Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis.

Authors:  Ludger Schöls; Peter Bauer; Thorsten Schmidt; Thorsten Schulte; Olaf Riess
Journal:  Lancet Neurol       Date:  2004-05       Impact factor: 44.182
  4 in total
  2 in total

1.  News on the journal Neurological Sciences in 2017.

Authors:  Ilaria Di Donato; Antonio Federico
Journal:  Neurol Sci       Date:  2018-01       Impact factor: 3.307

2.  Accurate detection of cerebellar smooth pursuit eye movement abnormalities via mobile phone video and machine learning.

Authors:  Zhuoqing Chang; Ziyu Chen; Christopher D Stephen; Jeremy D Schmahmann; Hau-Tieng Wu; Guillermo Sapiro; Anoopum S Gupta
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.